ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : Swiss Institute for Applied Cancer Research

Include trials that are no longer recruiting patients.

31 studies were found.
1.RecruitingAdjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer
Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer; Pain
2.RecruitingAntithymocyte Globulin and Cyclosporine Compared With Standard Therapy in Treating Patients With Myelodysplastic Syndrome
Conditions: Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ...
3.No longer recruitingBiological Therapy in Treating Patients With Bladder Cancer
Conditions: stage I bladder cancer; stage 0 bladder cancer
4.No longer recruitingCapecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
5.RecruitingCapecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer
6.RecruitingCapecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement
Condition: stage IV breast cancer
7.No longer recruitingCapecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Conditions: stage IV prostate cancer; recurrent prostate cancer
8.No longer recruitingChemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer
Condition: Ovarian Cancer
9.No longer recruitingChemotherapy in Treating Patients With Advanced Sarcoma
Conditions: stage IVB adult soft tissue sarcoma; stage III uterine sarcoma; stage IV uterine sarcoma; stage IVA adult soft tissue sarcoma; ...
10.RecruitingChemotherapy With or Without Radiation Therapy Before Surgery in Treating Patients With Non-Small Cell Lung Cancer
Conditions: Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; Adenosquamous Cell Lung Cancer
11.RecruitingCladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
12.RecruitingCombination Chemotherapy and Peripheral Stem Cell Transplantation With or Without Radiation Therapy and/or Surgery in Treating Patients With Ewing's Sarcoma
Conditions: localized tumors of the Ewing's family; metastatic tumors of the Ewing's family
13.RecruitingCombination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
Conditions: stage II gastric cancer; stage III gastric cancer
14.No longer recruitingCombination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung
Condition: localized malignant mesothelioma
15.RecruitingCombination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
Conditions: Squamous Cell Lung Cancer; large cell lung cancer; stage IIIB non-small cell lung cancer; Adenosquamous Cell Lung Cancer
16.RecruitingCombination Chemotherapy Followed by Radiation Therapy With or Without Surgery in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
17.No longer recruitingCombination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; Squamous Cell Lung Cancer; Adenocarcinoma of the Lung; large cell lung cancer
18.No longer recruitingCombination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer
Conditions: stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; stage IV colon cancer
19.No longer recruitingCombination Chemotherapy in Treating Patients With Advanced Stomach Cancer
Conditions: stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer
20.RecruitingCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
Conditions: adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma
21.RecruitingDaily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
Conditions: untreated hairy cell leukemia; progressive hairy cell leukemia, initial treatment; Prolymphocytic Leukemia
22.No longer recruitingDrugs to Reduce the Side Effects of Chemotherapy
Conditions: solid tumor; Nausea; Vomiting
23.No longer recruitingExemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
Conditions: stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
24.RecruitingGemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
Conditions: stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
25.No longer recruitingMonoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma
Conditions: noncontiguous stage II mantle cell lymphoma; stage IV mantle cell lymphoma; recurrent mantle cell lymphoma; contiguous stage II mantle cell lymphoma; ...
26.RecruitingNeoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer
Conditions: stage II esophageal cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus
27.No longer recruitingPaclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
Conditions: untreated adult acute myeloid leukemia; untreated adult acute lymphocytic leukemia; recurrent adult acute myeloid leukemia; ...
28.No longer recruitingRadiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer
Conditions: stage IV squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the hypopharynx; ...
29.No longer recruitingRituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy
Conditions: refractory hairy cell leukemia; progressive hairy cell leukemia, initial treatment
30.RecruitingTrastuzumab With or Without Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
Conditions: stage IV breast cancer; recurrent breast cancer
31.No longer recruitingVinorelbine in Treating Patients With Metastatic Prostate Cancer
Condition: stage IV prostate cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act